- Corporate Officers - C
- Coric Vlad
Insider Trading History of Coric Vlad
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Coric Vlad since 2017.
This trader's CIK number is 1704317.
At the time of last reporting, Coric Vlad was the Director of Veradermics, Inc. (stock ticker symbol MANE).
Also see all insider trading activities at Veradermics, Inc.
Note that in the past
Coric Vlad also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Veradermics, Inc (MANE) by Coric Vlad
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | MANE | 117,646 | $1,999,982 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biohaven Pharmaceutical Holding Co Ltd. (BHVN) by Coric Vlad
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | BHVN | 0 | $0 | 0 | $0 | 22,500 | $0 |
| 2021 | BHVN | 0 | $0 | 0 | $0 | 23,450 | $0 |
| 2020 | BHVN | 0 | $0 | 0 | $0 | 10,950 | $0 |
| 2019 | BHVN | 5,000 | $201,100 | 100,000 | $5,008,913 | 10,950 | $0 |
| 2018 | BHVN | 0 | $0 | 50,000 | $1,750,899 | 0 | $0 |
| 2017 | BHVN | 0 | $0 | 150,000 | $4,451,700 | 0 | $0 |
Yearly summary of insider trading at Biohaven Ltd. (BHVN) by Coric Vlad
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | BHVN | 0 | $0 | 0 | $0 | 14,250 | $0 |
| 2025 | BHVN | 666,666 | $4,999,995 | 0 | $0 | 14,250 | $0 |
| 2024 | BHVN | 143,003 | $5,999,961 | 0 | $0 | 0 | $0 |
| 2023 | BHVN | 454,545 | $9,999,990 | 0 | $0 | 0 | $0 |
| 2022 | BHVN | 653,505 | $7,649,219 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Coric Vlad:
1. Veradermics, Inc (MANE)
2. Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
3. Biohaven Ltd. (BHVN)
Table 1. Insider trading of Veradermics, Inc (MANE) by Coric Vlad
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-02-05 | MANE | Buy | 117,646 | 17.00 | 1,999,982 |
Table 2. Insider trading of Biohaven Pharmaceutical Holding Co Ltd. (BHVN) by Coric Vlad
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-06 | BHVN | Option Ex | 12,500 | .00 | 0 |
| 2022-01-07 | BHVN | Option Ex | 10,000 | .00 | 0 |
| 2021-11-25 | BHVN | Option Ex | 10,950 | .00 | 0 |
| 2021-01-06 | BHVN | Option Ex | 12,500 | .00 | 0 |
| 2020-11-25 | BHVN | Option Ex | 10,950 | .00 | 0 |
| 2019-12-18 | BHVN | Option Ex | 10,950 | .00 | 0 |
| 2019-06-26 | BHVN | Buy | 5,000 | 40.22 | 201,100 |
| 2019-03-14 | BHVN | Sale | 31,893 | 50.02 | 1,595,447 |
| 2019-03-13 | BHVN | Sale | 16,145 | 50.02 | 807,572 |
| 2019-03-12 | BHVN | Sale | 51,962 | 50.15 | 2,605,894 |
| 2018-06-01 | BHVN | Sale | 13,840 | 35.04 | 484,953 |
| 2018-05-30 | BHVN | Sale | 1,541 | 35.00 | 53,935 |
| 2018-05-31 | BHVN | Sale | 34,619 | 35.01 | 1,212,011 |
| 2017-11-01 | BHVN | Sale | 50,000 | 29.36 | 1,468,000 |
| 2017-10-31 | BHVN | Sale | 100,000 | 29.84 | 2,983,700 |
Table 3. Insider trading of Biohaven Ltd. (BHVN) by Coric Vlad
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-01-05 | BHVN | Option Ex | 14,250 | .00 | 0 |
| 2025-11-13 | BHVN | Buy | 666,666 | 7.50 | 4,999,995 |
| 2025-01-05 | BHVN | Option Ex | 14,250 | .00 | 0 |
| 2024-10-02 | BHVN | Buy | 21,052 | 47.50 | 999,970 |
| 2024-04-22 | BHVN | Buy | 121,951 | 41.00 | 4,999,991 |
| 2023-10-05 | BHVN | Buy | 454,545 | 22.00 | 9,999,990 |
| 2022-10-31 | BHVN | Buy | 25,800 | 15.97 | 412,000 |
| 2022-10-28 | BHVN | Buy | 141,930 | 14.85 | 2,106,950 |
| 2022-10-05 | BHVN | Buy | 485,775 | 10.56 | 5,130,269 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Coric Vlad
(Director of Veradermics, Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.